Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Asensus Surgical Stock Quote

Asensus Surgical (NYSEMKT: ASXC)

Price as of July 23, 2024, 4:00 p.m. ET

Asensus Surgical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ASXC -35.63% -98.03% -54.38% -98%
S&P +22.66% +84.28% +13.00% +237%

Asensus Surgical Company Info

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

News & Analysis

The Fool has written over 100 articles on Asensus Surgical.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.